Official 2024 U.S. DOL Form 5500 summary for Capsida Biotherapeutics, INC. (Capsida Biotherapeutics, INC. 401(k) Plan · EIN 83-4673583 · PN 001): $5.25M net assets, 116 active participants, and $10.96 per $10,000 (10.96 bps).
| Plan Sponsor | Capsida Biotherapeutics, INC. |
|---|---|
| Filing Identifier | Capsida Biotherapeutics, INC. 401(k) Plan · EIN 83-4673583 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (CA) |
| Asset-Size Peer Cohort | $1M-$5M |
| Plan Net Assets (2024) | $5.25M |
| Active Participants | 116 |
| Direct Admin Fee Rate | $10.96 per $10,000 (10.96 bps) |
| Cohort Peer Median | $63.02 per $10,000 (63.02 bps) |
| Primary Recordkeeper / Provider | Unbundled / Direct Trust |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($12,342, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI